S0622, Dasatinib in Treating Patients With Stage IV Breast Cancer That Has Spread to the Bone

Summary

RATIONALE: Dasatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. PURPOSE: This randomized phase II trial is studying two different schedules of dasatinib to compare how well they work in treating patients with stage IV breast cancer that has spread to the bone.

Timeline

Start

2007-03

Primary completion

2013-01

Completion

2014-01

Drugs

Indications